Global Markets Direct Market Research Reports

TITLE Actions
Psychosis (Central Nervous System) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Psychosis (Central Nervous System) - Drugs in Development, 2021 Summary Psychosis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Psychosis pipeline landscape. The report provid...

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Developmen...

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Summary T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 provides in ...

Claudin 18 (CLDN18) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Claudin 18 (CLDN18) - Drugs in Development, 2021 Summary Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report provides comprehensive in...

RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 Summary RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 provides in depth analysis on RNA Directed RNA Polymerase (EC 2.7.7.48) ta...

Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Fibrosis pipeline landscape. The report p...

Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Summary Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Glycogen Storage Disease 1A pipeli...

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021 ...

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Summary Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 provides in depth ...

Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021 Summary ...

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pipeline landscape. ...

Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Inherited Mitochondria...

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Summary Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Like Protein 1 (NPC1L1) targeted...

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Summary Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H ...

Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Summary Cells Expressing Folate Recep...

Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Inflammation pipeline landscape. ...

X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021
Published in Apr 2021 | US $ 2000 Onwards | By Global Markets Direct

X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Summary X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the X-Linked SCID pipeline landscape. The report prov...

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Summary Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 provides in dept...

CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021 Summary CX3C Chemokine Receptor 1 (Beta C...

Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021
Published in Apr 2021 | US $ 3000 Onwards | By Global Markets Direct

Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Summary Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 provides i...

We are on:

Need Help?

To know about discount offers contact us at [email protected]